A Meta-Analysis of the Neuropsychological Effects of Adjuvant Chemotherapy Treatment in Women Treated for Breast Cancer

REFERENCES

• Ahles , T. & Saykin , A. J. ( 2002 ). Breast cancer chemotherapy-related congnitive dysfunction . Clinical Breast Cancer , 3 ( Suppl. ), S84 – S90 [PUBMED] [INFOTRIEVE] [CSA]
   Google Scholar
• Ahles , T. , Saykin , J. , Furstenberg , T. , Cole , B. , Mott , L. A. , et al. . ( 2002 ). Neuropsychologic impact of standard-dose systemic chemotheraphy in long-term survivors of breast cancer and lymphoma . Journal of Clinical Oncology , 20 , 485 – 493 [PUBMED] [INFOTRIEVE] [CROSSREF] [CSA]
   PubMed Web of Science ®Google Scholar
• Anderson-Hanley , A. , Sherman , M. L. , Riggs , R. , Agocha , V. B. , & Compass , B. E. ( 2003 ). Neuropsychological effects of treatments for adults with cancer: A meta-analysis and review of the literature . Journal of the International Neuropsychological Society , 9 , 967 – 982 [PUBMED] [INFOTRIEVE] [CROSSREF] [CSA]
   PubMed Web of Science ®Google Scholar
• Anderson-Hanley , A. , Sherman , M. , Riggs , R. , Compass , B. , & Agocha , B. ( 2002 ). The neuropsychological effects of treatments for cancer: A meta-analysis . Poster session presented at the 30th annual meeting of the International Neuropsychological Society , February , Toronto , Canada .
   Google Scholar
• Asato , R. , Akiyama , Y. , Ito , M. , Kubota , M. , Okumura , R. , et al. . ( 1992 ). Nuclear magnetic resonance abnormalities of the cerebral white matter in children with acute lymphoblastic leukemia and malignant lymphoma during and after central nervous system prophylactic treatment with intrathecal methotrexate . Cancer , 70 , 1997 – 2004 [PUBMED] [INFOTRIEVE] [CSA]
   PubMed Web of Science ®Google Scholar
• Barton , D. & Loprinizi , C. ( 2002 ). Noval approaches to preventing chemotherapy-induced congnitive dysfunction in breast cancer: The art of the possible . Clinics in Breast Cancer , 3 ( Suppl. ), S121 – S127 [CSA]
   Google Scholar
• Bender , C. M. , Paraska , K. K. , Sereika , S. M. , Ryan , C. M. , & Berga , S. L. ( 2001 ). Cognitive function and reproductive hormones in adjuvant therapy for breast cancer. A critical review . Journal of Pain and Symptom Management , 21 , 407 – 424 [PUBMED] [INFOTRIEVE] [CROSSREF] [CSA]
   PubMed Web of Science ®Google Scholar
• Brezden , C. B. , Philips , K.-A. , Abdolell , M. , Bunston , T. , & Tannock , I. F. ( 2000 ). Cognitive function in breast cancer patients receiving adjuvant chemotherapy . Journal of Clinical Oncology , 18 , 2695 – 2701 [PUBMED] [INFOTRIEVE] [CSA]
   PubMed Web of Science ®Google Scholar
• Castellon , S. A. , Ganz , P. A. , Bower , J. E. , Petersen , L. , Abraham , L. , & Greendale , G. A. ( 2004 ). Neurocognitive performance in breast cancer survivors exposed to adjuvant chemotheraphy and tamoxifen . Journal of Clinical and Experimental Neuropsychology , 26 , 955 – 969 [PUBMED] [INFOTRIEVE] [CSA]
   PubMed Web of Science ®Google Scholar
• Freeman , I. R. & Broshek , D. K. ( 2002 ). Assessing cognitive dysfunction in breast cancer—What are the tools? Clinical Breast Cancer , 3 ( Suppl. ), S91 – S99 [PUBMED] [INFOTRIEVE] [CSA]
   PubMedGoogle Scholar
• Gralow , J. (1999). What is the five-year survival rate for women newly diagnosed with breast cancer? (On-line). Available at www.healthtalk.com/bcen/toc/survival/01.html, January 10th, 2005.
   Google Scholar
• Hannay , H. J. & Lezak , M. D. ( 2004 ). The neuropsychological examination: Interpretation () , 4th ed . In M. D. Lezak , D. B. Howieson , & D. W. Loring (Eds.), Neuropsychological assessment (pp. 133 – 156 ). New York : Oxford University Press .
   Google Scholar
• Koch Nogueir , P. C. , Hadj-Aissa , A. , Schell , M. , Dubourg , L. , Brunt-Mentigny , M. , & Cochat , P. ( 1998 ). Long-term nephrotoxicity of cisplatin, ifosfamide, and methotrexate in osteosarcoma . Pediatric Nephrology , 12 , 572 – 575 [CROSSREF] [CSA]
   PubMed Web of Science ®Google Scholar
• Lee , Y.-Y. , Nauert , C. , & Glass , P. ( 1986 ). reatment-related white matter changes in cancer patients . Cancer , 57 , 1473 – 1482 [PUBMED] [INFOTRIEVE] [CSA]
   PubMed Web of Science ®Google Scholar
• Lipsey , M. W. & Wilson , D. B. ( 2001 ). Practical meta-analysis . Thousand Oaks , CA : Sage Publications .
   Google Scholar
• Loescher , L. J. , Welch-McCaffrey , D. , Leigh , S. A. , Hoffman , B. , & Meyskens , F. L. ( 1989 ). Surviving adult cancers: Part 1: Physiologic effects . Annals of Internal Medicine , 111 , 411 – 432 [PUBMED] [INFOTRIEVE] [CSA]
   PubMed Web of Science ®Google Scholar
• Ludwig , H. & Strasser , K. ( 2001 ). Symptomatology of anemia . Seminars in Oncology , 28 , 7 – 14 [PUBMED] [INFOTRIEVE] [CROSSREF] [CSA]
   PubMed Web of Science ®Google Scholar
• Maraveyas , A. & Mansi , J. L. ( 2001 ). The management of the side-effects of adjuvant therapy including chemotherapy and endocrine effects . In J. M. Dixon (Ed.), Breast cancer: Diagnosis and management (pp. 337 – 346 ). New York : Elsevier Science .
   Google Scholar
• Marina , N. ( 1997 ). Long-term survivors of childhood cancer. The medical consequences of cure . Pediatric Oncology , 44 , 1021 – 1042 [CSA]
   Google Scholar
• Meyer , C. A. , Burns , K. S. , & Komaki , R. ( 1995 ). Cognitive deficits in patients with small cell lung cancer before and after chemotherapy . Lung Cancer , 12 , 231 – 235 [CROSSREF] [CSA]
   PubMed Web of Science ®Google Scholar
• Meyers , C. A. , Scheibel , R. S. , & Forman , A. D. ( 1991 ). Persistent neurotoxicity of systemically administered interferon-alpha . Neurology , 41 , 672 – 676 [PUBMED] [INFOTRIEVE] [CSA]
   PubMed Web of Science ®Google Scholar
• Moore , L. M. , Packer , R. J. , Karl , D. , & Bleyer , W. A. ( 1994 ). Adverse effects of cancer treatment on the central nervous system . In C. L. Schwartz & W. L. Hobbie (Eds.), Survivors of childhood cancer . (pp. 81 – 95 ), St. Louis : Mosby .
   Google Scholar
• Okeda , R. , Karakama , T. , Kimura , S. , Toizumi , S. , Mitsushima , T. , & Yokoyama , Y. ( 1984 ). Neuropathologic study on chronic neurotoxiticy of 5-fluorouracil and its masked compounds in dogs . Acta Neuropathologica , 63 , 334 – 343 [PUBMED] [INFOTRIEVE] [CROSSREF] [CSA]
   PubMed Web of Science ®Google Scholar
• Olin , J. J. ( 2001 ). Congnitive function after systemic therapy for breast cancer . Oncology , 15 , 613 – 624 [PUBMED] [INFOTRIEVE] [CSA]
   PubMed Web of Science ®Google Scholar
• Orwin , R. G. ( 1983 ). A fail-safe N for effect size in meta-analysis . Journal of Educational Statistics , 8 , 157 – 159 [CSA]
   Google Scholar
• O'Shaughnessy , J. A. ( 2002 ). Effects of epoetin alfa on cognitive function, mood, asthenia, and quality of life in women with breast cancer undergoing adjuvant chemotherapy . Clinical Breast Cancer , 3 ( Suppl. ), S116 – S120 [PUBMED] [INFOTRIEVE] [CSA]
   Google Scholar
• O'Shaughnessy , J. A. ( 2003a ). Chemotherapy-related congnitive dysfunction in breast cancer . Seminars in Oncology Nursing , 19 , 17 – 24 [PUBMED] [INFOTRIEVE] [CROSSREF] [CSA]
   PubMedGoogle Scholar
• O'Shaughnessy , J. A. ( 2003b ). Chemotherapy-induced cognitive dysfunction: A clearer picture . Clinical Breast Cancer , 4 ( Suppl. ), S89 – S94 [PUBMED] [INFOTRIEVE] [CSA]
   PubMedGoogle Scholar
• Paganini-Hill , A. & Clark , L. J. ( 2000 ). Preliminary assessment of cognitive function in breast cancer patients treated with tamoxifen . Breast Cancer Research and Treatment , 64 , 165 – 176 [PUBMED] [INFOTRIEVE] [CROSSREF] [CSA]
   PubMed Web of Science ®Google Scholar
• Pheby , D. ( 2001 ) Breast Cancer: Current trends and future hopes (On-line). Available at www.positivehealth.com/permit/Articles/Cancer/pheby.html, January 10, 2005 .
   Google Scholar
• Rosenthal , R. ( 1991 ). Meta-analytic procedures for social research () , rev. ed. . Newbury Park , CA : Sage .
   Google Scholar
• Rosenthal , R. & DiMatteo , M. R. (2001). Meta-analysis: Recent developments in quantitative methods for literature reviews. Annual Review in Psychology , 52, 59–82 [CROSSREF] [CSA]
   PubMed Web of Science ®Google Scholar
• Rugo , H. S. & Ahles , T. ( 2003 ). The impact of adjuvant therapy for breast cancer on cognitive function: Current evidence and directions for research . Seminars in Oncology , 6 , 749 – 762 [CROSSREF] [CSA]
   Google Scholar
• Schagen , S. B. , Muller , M. J. , Boogerd , W. , & van Dam , F. S. A. M. ( 2002 ). Cognitive dysfunction and chemotherapy: Neuropsychological findings in perspective . Clinical Breast Cancer , 3 ( Suppl. ), S100 – S108 [PUBMED] [INFOTRIEVE] [CSA]
   Google Scholar
• Schagen , S. B. , Van Dam , F. S. A. M. , Muller , M. F. , Boogerd , W. , Lindeboom , J. , & Bruning , P. F. ( 1999 ). Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma . Cancer , 85 , 640 – 650 [PUBMED] [INFOTRIEVE] [CROSSREF] [CSA]
   PubMed Web of Science ®Google Scholar
• Schwartz , C. ( 1995 ). Late effects of treatment in long-term survivors of cancer . Cancer Treatment Review , 21 , 355 – 366 [CROSSREF] [CSA]
   PubMed Web of Science ®Google Scholar
• Schwarzer , R. ( 1988 ). Meta-analysis program . Behavior, Research Methods, Instruments, & Computers , 20 , 338 [CSA]
   Google Scholar
• Sherwin , B. ( 1997 ). Estrogen effects o cognition in menopausal women . Neurology , 48 , S21 – S26 [PUBMED] [INFOTRIEVE] [CSA]
   Web of Science ®Google Scholar
• Silberfarb , P. M. ( 1983 ). Chemotheraphy and cognitive defects in cancer patients . Annual Review in Medicine , 137 , 597 – 601 [CSA]
   Google Scholar
• Stewart , A. , Collins , B. , Bielajew , C. , & Tomiak , E. ( 2003 ). Neuropsychological functioning in breast cancer patients prior to systemic therapy in comparison to published norms . Presented at the American Neuropsychiatric Association annual conference , February, Honolulu .
   Google Scholar
• Tchen , N. , Juffs , H. G. , Downie , F. P. , Yi , Q.-L. , Hu , H. , et al. . ( 2003 ). Cognitive function, fatigue, and menopausal symptoms in women receiving adjuvant chemotherapy for breast cancer . Journal of Clinical Oncology , 21 , 4175 – 4183 [PUBMED] [INFOTRIEVE] [CROSSREF] [CSA]
   PubMed Web of Science ®Google Scholar
• Van Dam , F. S. A. M. , Schagen , S. B. , Muller , M. J. , Boogerd , W. , Wall , E. V. D. , et al. . ( 1998 ). Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: high-dose versus standard-dose chemotherapy . Cancer , 90 , 210 – 218 [CSA]
   Web of Science ®Google Scholar
• Wefel , J. S. , Lenzi , R. , Theriault , R. L. , Davis , R. N. , & Meyers , C. A. ( 2004 ). The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: Results of prospective, randomized, longitudinal trial . Cancer , 100 , 2292 – 2229 [PUBMED] [INFOTRIEVE] [CROSSREF] [CSA]
   PubMed Web of Science ®Google Scholar
• Wieneke , M. H. & Dienst , E. R. ( 1995 ). Neuropsychological assessment of cognitive functioning following chemotherapy for breast cancer . Psycho-Oncology , 4 , 61 – 66 [CSA]
   Web of Science ®Google Scholar